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Abstract
Alkaloids have been known for several centuries and have been mainly obtained from 
natural sources that presented important properties with biochemical, pharmacologi-
cal, and medical effects in living organisms. Alkaloids are derived from amino acids like 
other important molecules in the functioning of life in our body. Hence, alkaloids are 
considered as pharmacologically important. Alkaloids are secondary metabolites widely 
distributed in leaves, stem, root, and fruits of plants which synthesize them. However, 
administration and consumption of them at right doses are beneficial in terms of health; 
excess doses will be definitely poisonous and may cause even death. The pharmacological 
activities of alkaloids are quite diverse. They are important natural products with a wide 
range of medicinal properties including relief of pain (e.g., morphine), analgesic (e.g., 
codeine), antiarrhythmic (e.g., quinidine), antibacterial (e.g., chelerythrine), antiasthma 
(e.g., ephedrine), cholinomimetic (e.g., galantamine), and vasodilatory (e.g., vincamine).
Keywords: alkaloids, local anesthetics, pain relief, analgesia, natural products, mechanism 
of action, bioorganic chemistry
1. Introduction
MERGEFORMAT plants have been used from ancient times as an excellent source of phar-
maceutical compounds in the treatment of diseases and have solid impact on human health. 
Modern chemistry and material sciences have identified the compounds with pharmacologi-
cal properties for the development of new drugs. Hence, they have played a major role in 
drug discovery as natural products and synthetic materials which do not exist in the nature 
and can only be produced.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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The presence of some chemical substances in plant tissues produces a physiological action on 
the body and regulates the metabolic activity. For example, these chemicals give plants their 
color or act as defense system based on their toxic effects. Alkaloids have been known for 
several centuries and have been mainly obtained from natural sources that presented impor-
tant properties with biochemical, pharmacological, and medical effects in living organisms. 
Alkaloids are secondary metabolites widely distributed in leaves, stem, root, and fruits of 
plants which synthesize them. However, administration and consumption of them at right 
doses are beneficial in terms of health; excess doses will be definitely poisonous and may 
cause even death. Many alkaloids extracted from plants showed anticholinesterase activity 
[1, 2] and antioxidant [3], anxiolytic [4], antimicrobial [5], anti-HIV [6], antiparasitic [7], anti-
inflammatory [8], and antidepressant [9] properties. After the recognition of vital importance 
of these nitrogenous secondary metabolites, they are found in animals too [10]. In spite of the 
investigations on the biological activity of some alkaloids, only a few could be produced com-
mercially due to their complex chemical structures. The synthetic production of some impor-
tant alkaloid is more common than their isolation from plants. In addition, there are other 
synthetic compounds that are closely related to the natural alkaloids but lack of some typical 
properties (e.g., homatropine) [11].
Alkaloids display antimicrobial and antiparasitic properties, act as narcotics, can alter DNA, 
have an important role in the immune systems, and treat cardiovascular and metabolic dis-
orders, inflammation, infectious diseases, and miscellaneous problems [10, 12–19]. Therefore, 
modern medicine tends to produce pharmaceuticals on the basis of natural alkaloids and 
alkaloids with modified structure such as aconitine, ajmaline, berberine, morphine, caffeine, 
theophylline, ephedrine, atropine, scopolamine, reserpine, and pilocarpine. There are several 
morphine-containing drugs that are used in cases of surgical operations and postoperative 
treatments (i.e., Morphalgin, Spasmofen, and Morphin) [20, 21].
2. History
The human race has used alkaloids in the scope of medicinal and pharmaceutical importance 
even before their discovery as chemical molecules. There are records from the Babylonian, 
ancient Hebrew, Egyptian, Chinese, Greek, and Assyrian times, such as Sanskrit writings and 
the works of Hippocrates, showing that they were all familiar with medicinal plants and alka-
loids to improve the health in the early 5000 BC. The most prominent examples of medicinal 
plants based on the earlier beliefs and knowledge were myrrh, opium, cannabis, aloes, cas-
sia, and hemlock. For example, native people of America and tribes in the Amazon used the 
alkaloid quinine in herbal before its official use in the cure of uncomplicated malaria in 1638. 
The latex of opium poppy (Papaver) was already in use in the Middle East and Greece at 1200 
BC. The roots of the mandrake plant were used because of sedative properties from the time 
of Hippocrates (ca. 400 BC). All alkaloids cause a physiological effect on the human body, 
and different poisonous alkaloids such as the ergot alkaloid, aconitine, and tubocurarine have 
been used for toxic purposes in ancient time. The poisonous alkaloids were prepared from 
plants (also from animal sources) and used as poisons for arrows by hunters in different parts 
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of the world. Literature also refers that some alkaloids including aconitine, atropine, colchi-
cine, coniine, ephedrine, ergotamine, mescaline, morphine, strychnine, psilocin, and psilocy-
bin have been used in executions. Philosopher Socrates was sentenced to death by consuming 
a cup of hemlock which contains the alkaloid coniine in 399 BC [11, 22–31].
Despite the fact that alkaloids have been in use for ages, actual studies on isolation from 
plants as relatively pure compounds occurred only in the beginning of the 1800s. In the late 
1700s, Lavoisier and others introduced the new developments in chemistry that leads many 
chemists to try to isolate the active ingredients in plants. The German pharmacist’s apprentice 
Friedrich Sertürner discovered the morphine in opium poppy by dissolving it in acid and 
neutralizing it with ammonia in 1804 for the first time in history. Morphine is considered 
for clinical purposes primarily a safe and effective way of pain relief. Although morphine is 
used clinically, drug addiction began with morphine and related substances. When Sertürner 
proved that the substance (morphine) he had isolated was indeed responsible for the actions 
of opium, chemists had isolated several other medically important substances such as qui-
nine, strychnine, and caffeine around that time. While the first use of the name “alkaloids” 
was in 1819 by a German chemist Carl F.W. Meissner, the term had an extensive usage after 
the publication of an article in the chemical dictionary of Albert Ladenburg in the 1880s [11, 
22–24, 32–37].
3. Properties
An exact and precise definition is somewhat difficult because of differences between the 
research fields of biology, medicine, and chemistry. The term alkaloid (alkali + oid) means 
alkali-like substance, and names of alkaloids end in -ine (e.g., atropine, cocaine, and mor-
phine). Many methods have been proposed for the classification of alkaloids such as phar-
macological, taxonomic, chemical, and biosynthetic classification. Although chemical 
classification based on the carbon skeleton is the most accepted way of classification, here we 
will use the pharmacological one depending on the physiological response. Alkaloids are a 
class of organic compounds that is made up of carbon, hydrogen, oxygen, and nitrogen. In 
addition, sulfur and rarely other elements such as chlorine, bromine, and phosphorus are 
also included in the alkaloids. Primary nitrogenous metabolites including amino acids and 
polymer of amino acids serve as precursors for alkaloids and are usually largely retained in 
the structure where the nitrogen in the alkaloid molecule is derived. In particular, alkaloids 
are synthesized from amino acids mostly derived from four different amino acids: lysine, 
phenylalanine, tyrosine, and tryptophan. To this respect alkaloids show similar structural 
features to the originated amino acid (shown in Figure 1). Alkaloids usually have one or more 
heterocyclic ring structure which includes at least one nitrogen atom in the ring. Nevertheless, 
the nitrogen atom is not within a carbon ring in some alkaloids such as mescaline. They are 
alkaline in nature due to the nitrogen content that they can absorb acid or hydrogen ions 
making them a base; however, some do not exhibit alkaline properties. The fact remains that 
the precise position of the nitrogen atom in the carbon ring or molecule varies with different 
alkaloids that determines the properties of them [24, 38–40].
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From the first impression, the term “secondary metabolite” looks like it is used to describe lit-
tle importance to plant metabolism or unrelated compounds, although they have broad func-
tional spectrum of specialized metabolism such as defense mechanisms and serve as bioactive 
compounds for drug discovery, and also other roles have not yet been clearly understood in 
the plant. It is a matter of controversy among scientists how alkaloids as secondary metabo-
lites make contribution to plants. Some believe that the presence of alkaloids discourages 
insects and animals from eating plants. Nonetheless, the general properties of alkaloids could 
be listed as colorless, crystalline solids and nonvolatile, optically active, bitter taste, soluble 
in organic solvents (i.e., alcohol, ether, chloroform). On the contrary their corresponding salts 
are highly soluble in water. There are a few liquids such as coniine and nicotine and even a 
few colored such as berberine is yellow [24, 40, 41].
Alkaloids can form ionic bonds with phenolic hydroxyl groups; hydrogen bonds with 
hydroxyl groups, carbonyl, or keto groups; and van der Waals and hydrophobic interactions 
with lipophilic compounds. These interactions will lead a conformational change in the pro-
tein structure that is usually associated with a loss or reduction in the bioactivities of proteins 
(enzymes, receptors, ion channels, hormones, etc.). Apart from other secondary metabo-
lites, alkaloids more specifically interact solely with a single particular target. For example, 
neurotransmitters and alkaloids both derive from amino acids as a consequence consist of 
structural similarities and are considered as analogs of each other. Alkaloids can bind to neu-
roreceptors, either activate (agonists) or inactivate (antagonists) them, and inhibit or activate 
ion channels such as the Na+, K+, and Ca2+ channels. Alkaloids have shown significant action 
for the treatment of such dangerous human diseases as cancer, AIDS, and lung diseases [22, 
40, 41]. Neurodegenerative diseases (ND) such as Alzheimer’s (AD) disease and dementia 
primarily affect the neurons in the human (central nerve system) which control many direct 
body functions and the behavior. The alkaloids show promising pharmacological activities 
for the treatment of neurodegenerative diseases such as Alzheimer’s disease. Clinical stud-
ies of galantamine, which is an alkaloid obtained from daffodil (Narcissus tazetta), snowdrop 
(Galanthus nivalis), and snowflake (Leucojum aestivum), report the capability of stimulating 
nicotinic receptors that further enhance cognition and memory [42–49].
Figure 1. The amino acids used for alkaloid biosynthesis.
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4. Plants as a source of alkaloids
There is an enormous range of chemical compounds present in plants where alkaloids take 
place as a content of secondary metabolites. Alkaloid content is inhomogeneous and usu-
ally within a few percent over the plant tissues. Further, most plants produce a few types of 
closely related alkaloids, whereas some of them may contain several alkaloids in different tis-
sues of the same plants. Therefore, firstly there is a need on the extraction of their mixture and 
then separation of individual alkaloids. Medicinal bioactive compounds from raw extracts 
of the plants can be isolated by acid-base extraction. Pure alkaloids are not readily soluble in 
water, but found to be fairly soluble in organic solvents (ether, chloroform, alcohol, and oils), 
relatively nonpolar solvents (hexane, benzene, petroleum ether). On the contrary, alkaloids 
are mostly present in the corresponding salt form in the plant and almost freely soluble in 
water, mostly insoluble or relatively less soluble in many of organic solvents. As a group, 
alkaloids are easily extracted in acidic forms because of their basic and lipid properties and 
separated from other water-soluble materials [32, 33, 38, 49–52].
Usually, the dried and powdered plant source is extracted with lipophilic or nonpolar 
organic solvents such as 1,2-dichloroethane, chloroform, diethyl ether, benzene, or petro-
leum ether. Since the alkaloids present in the plant sources as the salt of acids, they are 
exposed to an alkaline medium to convert the alkaloid salts to the corresponding alkaloid 
bases. The extraction of the alkaloid bases from the bulk of the crude alkaloid solution is 
achieved again with a nonpolar solvent. The impurities from the plant in solution are dis-
solved by dilute aqueous acid and are washed away with water. Alkaloids have different 
solubilities in certain solvents and different reactivities with certain reagents because of the 
structural diversity [22, 53, 54].
The alkaloid-based drugs used today are of plant origin, and screening of plant extracts for 
alkaloids and other pharmacologically active compounds is still in progress for new drug 
discoveries. Chemists extensively investigated production of alkaloids in plants on a large 
scale, to make many derivatives of these natural compounds and improve technologies cor-
related to chemical preparation. The discoveries of high-value chemical compounds in plants 
serve as model structures for synthetic drugs and allow the large-scale production of them 
with improved properties. Recently, the deep sea bioenvironment is considered an extremely 
rich source of novel bioactive alkaloids since marine natural products represent a fascinating 
example of the large variety of secondary metabolites [22, 40, 55].
5. Fundamentals of alkaloid pharmacology
The most useful portion of the plant (e.g., roots and seeds, stem, leaves, bark, milky exudate, 
etc.) has gathered as drug which is called as crude drugs and has a long-standing place in 
medicine. In fact, the comprehensive knowledge on the crude drugs is the basis of pharmaceu-
tical sciences. A number of alkaloids are used as drugs owing to the important pharmacologi-
cal bioactivity in human bodies. In addition to natural alkaloids, synthetic and semisynthetic 
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alkaloids are discovered by chemical synthesis and modifications of natural alkaloids. Thus, 
synthetic and semisynthetic alkaloids are biologically more active with improved proper-
ties. For example, morphine potency has been dramatically increased via the addition of a 
14-hydroxy group to the morphine alkaloid structure. Moreover, scientific achievements 
have allowed discrimination of chemical structural differentiations (angle of valence of C, N, 
H, and moiety) of the alkaloid molecules that can lead into considerable changes in biologi-
cal activities. Therefore, the interdisciplinary research of bioorganic chemistry, biology, and 
pharmacology is becoming more important [41, 56–58].
For many years, scientific research has been tried to understand the nature and the function 
of alkaloids in plant metabolism. The role of alkaloids can be explained based on the func-
tions of these compounds inside and outside the organism producing them. Alkaloids play 
a protective or chemical defense role in interaction with other organisms. However, it is not 
entirely clear if this ecologically important role is a basic function of these compounds. New 
researches suggested this role may be a secondary function of alkaloids in connection with 
the regulation of metabolism as the result of gene expression. Moreover, alkaloids have a 
fundamental role inside the organism in which they occur and produced by the activity of the 
organism’s genes, enzymes, and proteins (i.e., quinolizidine alkaloids). Alkaloids are able to 
self-regulate by changing their structural chemical configurations and biological activity in 
different cell conditions according to pH changes.
Alkaloids and alkaloid-containing drugs became critical components of the pharmacology 
for clinical applications due to the tremendous healing capability [30]. Many methods have 
been proposed for the classification of alkaloids as pharmacological, taxonomic, chemical, and 
biosynthetic classification. Although chemical classification based on the carbon skeleton is 
the most accepted way of classification, here we will use the pharmacological one depending 
on the physiological response. In medicine, alkaloids mainly exhibit marked pharmacological 
activity in some serious disorders like cardiovascular and metabolic disorders, cancer, blood 
pressure, inflammation, infectious diseases, neurodegenerative diseases, and miscellaneous 
problems. They have been used as bronchodilator, cardiac stimulant (quinidine), muscle 
relaxant, pain killer, analgesic (codeine), antioxidant, anticancer (berberine), antimicrobial 
and amebicidal, anti-inflammatory, central nervous system stimulants or depressants, sym-
pathomimetics, purgative, vasodilator (vincamine), etc. Various pharmacological alkaloids 
are used in medicine with some examples as listed: atropine is widely used as an antidote to 
cholinesterase inhibitors and also used in drying cough secretions; morphine and codeine are 
narcotic analgesics, and codeine is also an antitussive agent; colchicine is used as a gout sup-
pressant; caffeine is a central nervous system stimulant further used as a cardiac and respira-
tory stimulant and as an antidote to barbiturate and morphine poisoning; emetine is used in 
the treatment of amebic dysentery and other protozoal infections; epinephrine or adrenaline is 
used as a bronchodilator and cardiac stimulant and antiallergic, anesthesia, and cardiac arrest; 
vincristine is used as anticancer drug; and ephedrine is used in blood pressure. Galantamine 
plays a vital role in treating cognitive disorders that cognitive dysfunction is a major health 
problem in the twenty-first century, by influencing the function of receptors for the major 
inhibitory neurotransmitters [22, 30, 54, 55, 59, 60].
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6. Alkaloids with anesthetic effects and the related mechanisms
Local anesthetics are the most effective drugs used for the provision of anesthesia and analgesia 
both intra- and postoperatively in medicine. They are also used to decrease temperature, touch 
proprioception, and skeletal muscle tone. Alkaloids in local anesthetics have been used in a vari-
ety of clinical situations such as topical application to the skin or mucosa membranes; injectable 
agents for peripheral, central, or spinal nerve block; and also anorectal or ophthalmic use. Local 
anesthetics consist of a lipophilic (soluble in lipids) aromatic ring connected to a hydrophilic 
amine ring (amide group) in the molecular structure. In all clinically used local anesthetics (except 
cocaine), these lipophilic and hydrophilic groups bind via an amide or ester, and the nature of 
this bond determines many of the properties of the agent (Figure 2). Cocaine, procaine, tetracaine, 
chloroprocaine, benzocaine, and amethocaine can be given as examples to esters, whereas lido-
caine (also known as lignocaine), bupivacaine, mepivacaine, prilocaine, etidocaine, dibucaine, 
ropivacaine, and levobupivacaine for amides. As can be noticed, the suffix “-caine” is a common 
ending for drugs containing alkaloids. The ester bond is less stable than amide bond so it can 
easily be broken in solution and cannot be stored for as long as amides. Amino esters undergo 
hydrolysis to derivatives of para-aminobenzoic acid (PABA) during the metabolic process in the 
blood which cause allergic reactions that range from urticaria to anaphylaxis. In contrast, amino 
amides are metabolized by enzymes in the liver, have long duration of activity, are heat stable, 
also rarely trigger an allergic reaction, and therefore are more commonly used than esters.
When using the local anesthetics, it should be adjusted according to the duration of the sur-
gical procedure and the anticipated degree of pain. For example, a short-acting agent (e.g., 
mepivacaine) will be useful for creation of excellent intraoperative conditions with minimum 
postoperative pain for a short operation. On the other hand, a long-acting anesthetic (e.g., 
ropivacaine) selection will be appropriate for a rotator cuff repair which involves a greater 
degree of postoperative pain. A given local anesthetic has different block durations and onset 
depending on the nerve or plexus blockade.
Figure 2. Para-aminobenzoic derivatives of local anesthetics (hydrolyzed by pseudocholinesterase in plasma).
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All local anesthetics (except cocaine) are vasodilators where vasodilation occurs via direct 
relaxation of peripheral arteriolar smooth muscle fibers. The enhanced vasodilator activity 
of a local anesthetic agent results in shorter duration of action because of faster absorption. 
A vasoconstrictor counteracts this vasodilatation by providing delayed vascular adsorption 
of local anesthetics and increases the duration of contact with nerve tissues. Epinephrine 
vasoconstricts arteries, in concentrations of 5 mcg/ml (1:200,000), and is commonly used to 
decrease the adsorption of lidocaine when combined with local anesthetics solution. This dos-
age of epinephrine will significantly reduce nerve blood supply of lidocaine regardless of 
the site of administration. Decrease in the absorption provides increased neuronal uptake, 
enhanced quality of anesthesia, and prolonged duration of action [22, 23, 41, 56, 59, 61].
The first local anesthetic used in the clinical practice was cocaine, an alkaloid from the leaves of 
Erythroxylum coca. The natives of South America have chewed the leaves of E. coca which grows 
wild in the Andes Mountains in Peru for the stimulant effect, and the systemic effects of chew-
ing these leaves had reached Europe from the time of the Spanish conquest. In 1860, Niemann 
isolated the pure alkaloid responsible for the properties of the coca leaves and produced pure 
white crystals which he named cocaine. He noted that it had a bitter taste and produced numb-
ness of the tongue, rendering an almost devoid sensation. A Russian physician Vassily von 
Anrep in 1880 demonstrated that subcutaneous injection of cocaine produces sensory block 
where the skin is insensitive to the prick of a pin. This had attracted the attention of Sigmund 
Freud, and he conducted a study of the anesthetizing properties of cocaine with assistance of 
his friend Carl Koller. Koller introduced its topical use into ophthalmology and found that 
cocaine is able to block signal conduction in nerves which led to its rapid medical use as a 
“local anesthetic” in both dentistry (1884) and in surgery (1885) in spite of its dangers (danger-
ous effect on the central nervous system, drug of addiction, mydriasis in eye surgery) [62–64].
In 1885, Leonard Corning produced spinal anesthesia both in a dog and a patient and pro-
duced block of the lower half of the body. Even though he suggested its feasibility, it could 
be performed in surgery several years after that. Quincke showed that lumbar puncture was 
a practical procedure in 1891 and the first spinal blocks for surgery was performed by August 
Bier in 1898.
The early use of cocaine was largely limited to topical application because of the toxicity of 
cocaine, difficulties in sterilization, drug addiction, and short duration of action. Later on, oth-
ers have been discovered with less abuse potential, low toxicity, and safer drugs like procaine 
and procainamide. The latest is lidocaine (synthetic local anesthetic considered prototype) 
where all new local anesthetics like amino amides have been introduced into clinical practice 
(Figure 3) [46, 47, 65].
6.1. Mechanism of action
Local anesthetics block the generation and the conduction in peripheral nerves by disruption 
of ion channel function within the neuron cell membrane preventing the transmission of the 
neuronal action. This is achieved by specific binding of alkaloids in anesthetics reversibly to 
sodium (Na+) channels, preventing the passage of Na+ through Na+ channels, and interaction 
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with receptors, holding them in an inactive state so that no further depolarization can occur. 
Local anesthetics primarily have the ability to bind to sodium channel pore when it is in acti-
vated state, although may bind during the resting inactivated state to make it impermeable 
to Na+ [62, 66–68].
Figure 3. Chemical structures of ester and amide local anesthetics.
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Sodium influx through these channels is necessary to function within the neuron cell mem-
brane for the transmission of the neuronal action potential and subsequent propagation of 
an impulse along the course of the nerve. Thus, the loss of sensation in the area supplied by 
the nerve provides loss of pain, temperature, touch, proprioception, and then skeletal muscle 
tone, respectively. When local anesthesia is used, people may still feel touch but not pain.
Physiologic activity of alkaloidal local anesthetics depends on lipid solubility, affinity for pro-
tein binding, percent ionization at physiologic pH, and vasodilating properties. Lipid solu-
bility is directly in correlation with the potency of the local anesthetic where the nerve cell 
membrane is composed of lipid and a depot of drug forms in the perineural lipid-rich tissues.
Through the lipid solubility, lidocaine penetrates in nerve membranes and binds to acute-
phase protein of α1-acid glycoprotein (AAG) which is responsible for binding lidocaine and 
other basic drugs. Although lidocaine can bind to albumin (low affinity, high capacity), AAG 
(low capacity, high affinity) is the major drug-binding macromolecule even with lower plasma 
concentration. Albumin is considered as the principal binding protein for acidic compounds, 
and AAG is the principal binding protein for basic drugs [69–72].
Alkaloids are weak bases and exist in ionized and nonionized forms which are defined by the 
dissociation constant (pKa) of a weak base and the pH of the tissues (usually at range 7.6–8.9). 
Alkaloids are able to self-regulate by changing their structural chemical configurations and 
biological activity in different cell conditions according to pH changes. The neutral base form of 
the local anesthetic is more lipophilic that makes pKa greater than 7.4 for most local anesthetics. 
A decrease in pH increases the proportions of ionized form and results the delayed onset of 
action. In the presence of inflammation, local anesthetics are less effective, and onset of action 
is slow. On the contrary, an increase in pH results increased nonionic form, and nonionized 
drug form is more ready to pass through the lipid cell membrane. Therefore, more nonionized 
drug at physiological pH will reach its target site more quickly and will have a faster onset of 
action. This explains why lignocaine has an enhanced onset of action than bupivacaine [69–72].
Local anesthetic is exposed to the more acidic axoplasmic side of the nerve when passed in the 
cell membrane. This leads to ionized form of the molecule which binds the sodium channel 
for blockade. Local anesthetics bind to serum α1-acid glycoproteins and other proteins. The 
duration of action for local anesthetics is based on high affinity against protein. As long as local 
anesthetic remains bound to nerve membranes, it provides an increased duration of action. 
Thus, the availability of free drug in the blood decreases which reduce the potential for toxicity.
Clinically, sodium bicarbonate is used to increase the pH of local anesthetic solutions. 
Nevertheless, it should be avoided from precipitation of anesthetic molecules over with alka-
linization. Protein binding is also correlated to enhance continued blockade that alkaloid 
more firmly binds to the protein of the sodium channel. All local anesthetics are vasodilators 
(except cocaine) where the vasodilator activity leads to faster absorption and thus shorter 
duration of action. Addition of different alkaloids in local anesthetic solutions, i.e., mostly 
preferred epinephrine or norepinephrine and phenylephrine, produces vasoconstriction and 
provides less absorption through vascular beds. Thus, more local anesthetic will be available 
for neural blockade.
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Local anesthetic sensitivity of nerve fibers differs to block generation and the conduction of 
nerve impulses. Small nerve fibers tend to be blocked more easily than larger fibers, and 
myelinated fibers are blocked sooner than non-myelinated fibers of the same diameter [22, 24, 
40, 56, 57, 59, 73, 74].
6.2. Cocaine
Cocaine is a natural alkaloid produced from leaves of the coca that blocks nerve impulses and 
local vasoconstriction secondary to inhibition of local norepinephrine reuptake. However, it 
has a limited clinical use because of its toxicity and the potential for abuse. In modern medi-
cine, cocaine is used primarily in topical anesthesia of the upper respiratory tract, where it’s 
combined with vasoconstrictor and local anesthetic properties [56, 59, 75].
6.3. Lidocaine
Lidocaine was developed by Lofgren after procaine, the most widely used cocaine deriva-
tive with a low pKa (7.7). Lidocaine is a local anesthetic of the amide type as well as cardiac 
depressant (antiarrhythmic) which has an ingredient of lidocaine hydrochloride alkaloid 
(C
14
H
22
N
2
O·HCl). Lidocaine hydrochloride is a white powder freely soluble in water where 
injection of sterile, nonpyrogenic solution of it is indicated for production of local or regional 
anesthesia by infiltration techniques (percutaneous injection) and intravenous regional anes-
thesia by peripheral nerve block techniques (brachial plexus and intercostal) and by central 
neural techniques (lumbar and caudal epidural blocks). Further, it has been administered by 
continuous intra-articular infusion (to control postoperative pain). Lidocaine binds to neuro-
nal membrane to stabilize and inhibit voltage-gated sodium channels for the initiation and 
conduction of impulses. Lidocaine has a very rapid onset of action that typically begins work-
ing within 4 min and an anesthetic half-life of about 1.6 h (30 min to 3 h). Therefore, lidocaine 
is suitable for infiltration, block, and surface anesthesia where its actions are more intense and 
its effects are more prolonged (when compared to procaine). Subdural and epidural anesthe-
sias bupivacaine or prilocaine are preferred as longer-acting substances [37, 57, 58, 76].
The rapid metabolism by the liver enzymes leads to biotransformation of lidocaine in some 
pathways including oxidative N-dealkylation, ring hydroxylation, cleavage of the amide link-
age, and conjugation. The pharmacologically active metabolites monoethylglycinexylidide 
and inactive glycinexylidide are produced as a result of N-dealkylation biotransformation 
that is a primary metabolism. Monoethylglycinexylidide has a longer half-life but also less 
potent than lidocaine. The rate of biotransformation of an amide local anesthetic significantly 
influences the anesthetic blood levels where increased blood levels can potentially increase 
toxicity. Approximately 90% of the dose of injected lidocaine undergoes biotransformation 
and is excreted in the form of various metabolites in the kidney, whereas less than 10% is 
excreted and unchanged.
The concentration of AAG and the concentration of free lidocaine affect the predictability of 
lidocaine toxicity where higher doses of lidocaine can be tolerated before encountering toxicity 
based on surgery type and certain disease states. For example, surgery, trauma, postoperative 
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inflammation, cancer, and myocardial infarctions cause an increase in α1-acid glycoprotein 
and lidocaine binding, thus reducing the free lidocaine plasma concentration [77].
Through the lipid solubility, lidocaine penetrates in nerve membranes and binds to acute-
phase protein of α1-acid glycoprotein (AAG) which is responsible for binding lidocaine 
and other basic drugs. Although lidocaine can bind to albumin (low affinity, high capac-
ity), AAG (low capacity, high affinity) is the major drug-binding macromolecule even with 
lower plasma concentration. Albumin is considered as the principal binding protein for 
acidic compounds, and AAG is the principal binding protein for basic drugs [37, 57, 58, 
76, 78, 79].
Cocaine is a natural alkaloid produced from leaves of the coca that blocks nerve impulses and 
local vasoconstriction secondary to inhibition of local norepinephrine reuptake. However, it 
has a limited clinical use because of its toxicity and the potential for abuse. In modern medi-
cine, cocaine is used primarily in topical anesthesia of the upper respiratory tract, where it’s 
combined with vasoconstrictor and local anesthetic properties [26].
6.4. Procaine
Procaine, the first synthetic derivative of cocaine, was created in 1904 with the trade name 
of Novocaine, from the Latin nov- (new) and -caine, a common ending for alkaloids used 
as anesthetics. Procaine, an amino ester, is a short-acting local anesthetic that is used as an 
injection for local infiltration and peripheral nerve block during surgery and other medical 
and dental procedures. Low potency, slow onset, and short duration of action are the char-
acteristics of procaine. Although its clinical use is largely confined to infiltration anesthesia 
and peripheral nerve block as sterile solutions in concentrations of 1 and 2% for injection, this 
drug is no longer available in the United States.
Procaine has a pKa of 8.9 where commercially prepared solutions have a pH of 5.5 to 6.0. 
Due to rapid hydrolysis by plasma cholinesterase, it has very short plasma half-life that is 
thought to be approximately 20 seconds. It has a very short duration of action based upon 
extremely poor protein binding. While toxicity associated with the use of procaine is quite 
a little, the use of procaine produces metabolite para-aminobenzoic acid which is associated 
with an increased rate of allergy [57, 80].
6.5. Benzocaine
Benzocaine is an amino ester that is a derivative of procaine with a pKa of 8.5 and pH in 
preparation between 4.5 and 6.0. Benzocaine binds to sodium channels and reversibly depo-
larizes the neuronal membrane, consequently blocking the initiation and conduction of 
nerve impulses. It has a slow onset, short duration, and moderate toxicity. Benzocaine is 
considered an oral anesthetic because it numbs the mouth by dulling the nerve endings in 
painful areas [81].
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6.6. Chloroprocaine
Chloroprocaine is a short-acting amino ester which is a chlorinated derivative of procaine. 
Because it is the most rapidly metabolized local anesthetic (by cholinesterase), it has an 
extremely short plasma half-life. Chloroprocaine has a pKa of 8.9, whereas prepared solu-
tions have a pH of 2.5 to 4.0. Although it has a high pKa value, characterized by rapid onset of 
action, it also has the least toxicity in the central nerve system and/or cardiovascular system 
among current agents in use.
Chloroprocaine has clinical usage mostly in epidural anesthesia and also in peripheral blocks 
with short duration, whereas combined usage with other long-acting, slow-onset local anes-
thetics such as bupivacaine and tetracaine to achieve rapid onset with prolonged duration is 
common.
Owing to the short duration of spinal chloroprocaine, it is a strong alternative to lidocaine for 
surgical blocks and short or ultrashort surgical procedures for outpatient anesthesia. Its use 
in a dose ranging between 30 and 60 mg for procedures lasting >60 min has been suggested 
in the literature [82].
6.7. Tetracaine
Tetracaine is a long-acting amino ester with a pKa of 8.6, and commercially prepared solu-
tions have a pH between 4.5 and 6.5. It has been used in spinal anesthesia if long duration 
of action is needed and also in various topical anesthetic preparations. When compared to 
the other commonly used ester local anesthetics, tetracaine is more slowly metabolized and 
considerably more toxic. It is significantly more potent and has a longer duration of action 
than procaine or chloroprocaine. Tetracaine is not recommended for peripheral nerve blocks 
owing to its slow onset and potential for systemic toxicity (may be greater if used with epi-
nephrine). It has clinical use in spinal anesthesia with and without the use of epinephrine 
leading in a considerably reliable and long-onset spinal anesthetic [80].
6.8. Mepivacaine
Mepivacaine is an intermediate-duration amino amide local anesthetic with a pKa of 7.6. In 
terms of pharmacologic properties, mepivacaine is often compared to lidocaine where mepi-
vacaine has similar onset of action with a slightly longer duration for infiltration anesthesia. 
When an intermediate-duration blockade is desired for peripheral nerve block techniques, 
1.5% mepivacaine is an attractive local anesthetic, particularly in high-risk cardiac patients. 
Low toxicity, rapid onset, dense motor block, and excellent diffusion properties through tis-
sue can be listed as characteristic of mepivacaine. Mepivacaine is clinically used as a local 
anesthetic for an epidural or spinal block and also used as an anesthetic for dental procedures. 
Some addictive people try to obtain this drug and inject it themselves because large doses of 
mepivacaine cause sedation, immobility, confusion, dissociation, and amnesia [83].
The Local Anesthetic and Pain Relief Activity of Alkaloids
http://dx.doi.org/10.5772/intechopen.69847
69
6.9. Bupivacaine
Bupivacaine is introduced in 1963 since then it has been one of the most commonly used 
long-acting local anesthetics in regional and infiltration anesthesia. The structural differ-
ence of bupivacaine from lidocaine is the amine-containing group that is a butylpiperidine. 
Bupivacaine is capable of producing prolonged anesthesia and analgesia, thus reduc-
ing the need for repeated administration and rarely required the addition of epinephrine. 
Epinephrine can be prolonged even further duration of blockade. Bupivacaine produces more 
sensory than motor block where anesthesia duration is from 4 to 16 h depending upon the site 
of injection and the concentration used. Bupivacaine stabilizes the neuronal membrane and is 
widely used both in neuraxial and peripheral nerve blockade. Bupivacaine hydrochloride has 
higher lipid solubility (logDpH 7.4 = 2.54) and a much decreased rate of hepatic degradation 
when compared to lidocaine. This characteristic makes bupivacaine more cardiotoxic than 
lidocaine. Because of its greater tendency to produce cardiotoxicity, large doses of bupiva-
caine should be avoided and is not recommended for intravenous regional analgesia. 0.5% 
bupivacaine is as effective as 2% lignocaine. Bupivacaine is widely used both in neuraxial and 
peripheral nerve blockade, infiltration anesthesia, spinal anesthesia, and epidural and caudal 
anesthesia. It is not recommended for intravenous regional analgesia because of cardiotoxic-
ity which is much more than other local anesthetics. When bupivacaine is used, the smallest 
effective dose is aimed to administer [84–86].
6.10. Ropivacaine
The studies on reducing the cardiotoxicity of bupivacaine resulted to development of ropi-
vacaine with similar physicochemical properties of onset, potency, and duration to those of 
bupivacaine. Ropivacaine is used in concentrations of 0.5% or higher and produces dense 
blockade with a slightly shorter duration than bupivacaine. The onset of blockade is almost as 
fast as 1.5% mepivacaine or 3% 2-chloroprocaine in concentrations of 0.75%. Having less car-
diotoxicity and central nerve system toxicity, reduced motor block, and an absolute difference 
in potency are mentioned in the literature as the advantages of ropivacaine over bupivacaine. 
However, it can be suggested that there may be no more than slight differences in onset, but 
no difference between ropivacaine and bupivacaine in duration of block. For these reasons, 
both drugs have been used as an effective long-acting local anesthetic in peripheral nerve 
blockade [84, 87, 88].
6.11. Levobupivacaine
Despite the effectiveness of bupivacaine as anesthetic, there are safety concerns related to 
cardiovascular and/or central nerve system toxicity. As a result levobupivacaine is being 
associated with a lower risk of toxicity alternative to bupivacaine. Levobupivacaine contains 
a single enantiomer of bupivacaine hydrochloride (the S-(-)-enantiomer of (±)-bupivacaine) 
where dexbupivacaine (R-(+)-enantiomers) is the other enantiomer of bupivacaine. The route 
of administration and concentration effects the onset and duration of sensory and motor block 
where levobupivacaine, dexbupivacaine, or bupivacaine has similar potency as an anesthetic. 
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However, levobupivacaine is consistently less toxic than bupivacaine. The clinical use of 
levobupivacaine includes surgical anesthesia or pain management during labor, postopera-
tive analgesia, lumbar epidural or intrathecal anesthesia, thoracic epidural anesthesia, periph-
eral nerve block, and infiltration anesthesia that have mostly investigated and compared with 
bupivacaine [84, 88].
6.12. Opiates
Opiate describes any of the narcotic opioid alkaloids found in opium plant (Papaver som-
niferum) that are morphine, codeine, thebaine, and papaverine or synthetic opioids that are 
derived from morphine and thebaine (oxycodone and hydrocodone). Opiates and its syn-
thesized derivatives are prescribed in medications used for pain relief with even stronger 
analgesic properties than their predecessors do. Opium itself contains over 25 different alka-
loids, whereas only morphine and codeine are used as opiate analgesics from the point of 
view of clinical significance. The majority of drugs appearing on a synthetic opioid list are 
derivatives of these medications. The list of opiate drugs includes natural opiate drugs from 
natural opium alkaloids and synthetic (synthetic and semisynthetic) opiate drugs, also called 
as opioids, made by chemical synthesis in the laboratory according to the chemical structures 
found in natural alkaloids.
Natural opiate drugs can be listed as morphine, codeine, thebaine, and oripavine. Synthesized 
versions of natural opiate drugs are Demerol, Fentanyl, Dilaudid, Norco, Lortab, Atarax, 
Methadone, and Buprenorphine. Semisynthetic medications are derived from the naturally 
occurring alkaloids where small concentrations of natural opium alkaloids go into the making 
of semisynthetic opiates, thus, a part of synthetic opiates. Semisynthetic opiate drugs include:
• Oxymorphone—contains the natural alkaloid, thebaine.
• Hydrocodone—contains the natural alkaloid, codeine.
• Oxycodone—contains the natural alkaloid, thebaine.
• Hydromorphone—contains the natural alkaloid, morphine.
The studies in the laboratory were focused on eliminating the risk for addiction of natural opi-
oid alkaloids and make even more effective than opium itself for relatively safe alternatives 
for treatment. However, opiates in any form always carry a risk for addiction. Fully synthetic 
alkaloids are synthesized from other chemicals and molecules that do not come from alka-
loids found in plants [61, 89].
Both of these natural and synthetic types of drugs bound to the active site on the receptors 
(called opioid receptors) from certain nerve cells in the brain, spinal cord, and gastrointestinal 
tract. Once the opioids injected into the epidural or subarachnoid space to manage acute or 
chronic pain, bound to the specific nerve cells in the brain, block a specific receptor site and 
sent inaccurate measures of the severity of the pain so that the person who has taken the drug 
will experiences less pain. Thus, opiate is used in combinations with a local anesthetic to 
both enhance the blockade and prolong analgesia in neuraxial blockade. Nevertheless, opioid 
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receptors do not exist in peripheral nerve so opiates do not have an effective clinical role in 
peripheral nerve blockade. Taking drugs in these classes also affect how the brain feels plea-
sure, in other words addictive [21, 90–94].
Completely synthetic alkaloid molecules called opioids are originally synthesized by phar-
maceutical companies because of their potency as an analgesic for the treatment of severe 
pain. As opposed to an opiate (natural opium alkaloid), they are very similar in structure 
to morphine, whereas the exact geometry of the molecule largely effects on determining the 
painkilling activity. For example, the drugs Levorphan and Dextrorphan are both mirror 
images of one another with quite similar structure to morphine. Levorphan, the left-handed 
molecule like naturally left-handed morphine, is several times more potent than morphine 
and is strongly addictive, while Dextrorphan, the right-handed molecule, has no analgesic 
ability and is also nonaddictive [21, 90–94].
6.12.1. Morphine
The main alkaloid morphine in opium poppy is a naturally occurring analgesic opioid and 
one of the most potent pain relievers. One of the most important uses of morphine in today’s 
clinical practice is relief of pain caused by heart attack or myocardial infarction. Morphine 
helps to ease the pain particularly before, during, and after major surgeries and acts as an 
anesthetic without decreasing consciousness. Morphine is a weak base with the pKa of about 
8.0 and has relatively low lipid solubility at physiological pH (Figure 4). Morphine exists 
mostly in ionized form that does not favor passage through the lipid membrane; thus, onset 
of action is relatively slow (15–30 min). The basic mechanism depends on the shape of the 
morphine molecule and its binding to the active site on the receptor protein. The ability of 
morphine to fit into the active site and block a specific receptor site on a nerve cell gives its 
analgesic properties. In this way the action of the pain receptor rules out and intercepts the 
pain signals reaching the brain. The specific opiate receptors are classified mainly as mu (μ), 
kappa (κ), and sigma (σ). In terms of analgesia effects, the mu (μ) is the most important recep-
tor type including at least two subtypes, μ1 and μ2, in which μ1 probably mediates analgesia. 
Morphine produces relaxation and sedation by depressing the nervous system [91, 93, 95].
Figure 4. Morphine structure, replacing the ─OH group shown in red with ─OCH
3
, produces codeine where heroin 
derives from replacing both the red and blue ─OH groups with OCOCH
3
.
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Hydromorphone is synthesized from morphine that is much stronger than morphine but has 
less side effects and a lower dependency rate. It is prescribed to treat severe pain or dry 
coughing (Dilaudid and Palladone).
Completely synthetic alkaloid molecules called opioids are originally synthesized by phar-
maceutical companies because of their potency as an analgesic for the treatment of severe 
pain. As opposed to an opiate (natural opium alkaloid), they are very similar in structure 
to morphine, whereas the exact geometry of the molecule largely effects on determining the 
painkilling activity. For example, the drugs Levorphan and Dextrorphan are both mirror 
images of one another with quite similar structure to morphine. Levorphan, the left-handed 
molecule like naturally left-handed morphine, is several times more potent than morphine 
and is strongly addictive, while Dextrorphan, the right-handed molecule, has no analgesic 
ability and is also nonaddictive.
6.12.2. Codeine
Codeine is another powerful analgesic derived from morphine (although it is less potent 
than morphine) by replacing one of the ─OH groups with a methoxy group (─OCH
3
) and 
was first used as a therapeutic antitussive (see structure below in Figure 5). When codeine is 
metabolized, the ─OCH
3
 group converted back to ─OH and regenerates morphine. Although 
morphine, heroine, and codeine are all derived from opium, codeine has a slight difference 
in chemical structure from morphine and heroine. It is often sold as a salt in the form of 
either codeine sulfate or codeine phosphate, while codeine hydrochloride is more common 
worldwide. In therapeutic doses, codeine is much less effective as an analgesic than morphine 
therefore often combined with other medications including Empirin with codeine, Fiorinal 
with codeine, and Tylenol with codeine. The prescription medications of codeine is available 
in pill form but also can be injected into the muscle. It is not given through IV as it can cause 
convulsions. Codeine is used for its analgesic, antitussive, antidiarrheal, antihypertensive, 
anxiolytic, antidepressant, sedative, and hypnotic properties [21, 96].
Figure 5. Replacing the ─OH group of morphine shown in red with ─OCH
3
 produces codeine.
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6.12.3. Heroin
Heroin was synthesized from morphine to be used as a nonaddictive cure; however, it was turned 
out that heroin is highly addictive and more potent than morphine. Heroin exhibits euphoric, 
anxiolytic, and analgesic central nervous system properties so classified as a Schedule I drug that 
possession or trading of it is illegal. Heroin (diacetylmorphine or diamorphine) is derived from 
the morphine alkaloid by acetylation of the two hydrogen-bonding hydroxyl groups (─OH) with 
acetyl chloride (─OCOCH
3
) (Figure 6). Acetylation makes heroin more soluble in nonpolar sol-
vents (i.e., oils and fats) and provides rapid pass through the blood-brain barrier which makes 
heroin much more potent than morphine because heroin is converted back to morphine in the 
brain. Patients with heroin addiction should seek advice from healthcare providers [91, 93, 95].
6.12.4. Thebaine
Thebaine is a natural alkaloid that is extracted from the opium poppy plant, due to its origin 
classified as opiates. Though thebaine is toxic and unsuitable for use as drug, pharmaceu-
tical companies use thebaine alkaloids to create semisynthetic therapeutic drugs including 
Naloxone, Naltrexone, and Buprenorphine by breaking down it into smaller metabolites and 
also alter the chemical structure such as oxycodone. In spite thebaine binds to opioid recep-
tors in the central nervous system, it stimulates the nervous system, while morphine and 
codeine produce relaxation and sedation by depressing the nervous system.
Thebaine is used to create semisynthetic pain relievers, such as oxymorphone and oxyco-
done. Oxycodone is synthesized from thebaine and used to treat moderate to severe pain for 
patients after surgery. Oxycodone is usually prescribed in tablet forms (Percocet, Percodan, 
or OxyContin) and widely combined with other drugs such as aspirin. Hydrocodone is syn-
thesized from either codeine or thebaine and prescribed to treat moderate to severe pain and 
heavy coughs (Vicodin, Lorcet, Dolorex, Forten, and Anexsia).
Figure 6. Chemical structure of heroin derived from morphine.
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6.12.5. Oripavine
Oripavine is not produced by traditionally cultivated varieties of opium poppy where a chain 
of chemical processes are used to extract oripavine from the opium poppy plant. First of all 
opium is broken to major alkaloid metabolites, codeine, morphine, and thebaine. Oripavine 
is the major metabolite of thebaine that is produced by altering the chemical structure of the-
baine for more effective or safer medications. Despite its development based on high thera-
peutic value and low-abuse potential compounds, it has severe toxicity and low therapeutic 
index. Even though oripavine is a strong pain reliever with comparable analgesic potency to 
morphine, it does not have clinical use. It is used as convenient source for the production of 
several synthetic opioid pharmaceuticals [97].
6.12.6. Fentanyl
Fentanyl is one of the most lipophilic opioids with rapid onset of action (10–15 min) and short 
duration (2–5 h) that found a wide usage epidural and intradural for postoperative pain. The 
clinical studies also focused on the beneficial effect of the combination of intrathecal fentanyl 
as lipophilic opioids with intrathecal local anesthetic in ambulatory surgery. Intrathecal bupi-
vacaine is commonly preferred for local anesthesia in ambulatory surgery due to neurologi-
cal toxicity of lidocaine. The fact remains that a high level of the sympathetic block can take 
place in high doses of intrathecal bupivacaine. The combination of intrathecal opioids added 
to low-dose local anesthetics provides a faster onset of blockade and better intraoperative and 
immediate postoperative analgesia that prevents increasing the degree of motor blockade or 
delaying discharge [98–100].
6.13. Other anesthetic alkaloids
Tropane alkaloids are synthesized from the amino acids ornithine, putrescine (decarboxyl-
ated ornithine), and proline or obtained by extraction from plants. The important drugs and 
alkaloids in this group are atropine, hyoscyamine, and scopolamine. These alkaloids have 
effects on the central nervous system, including nerve cells of the brain and spinal cord that 
may also affect the autonomic nervous system. The chemical structure of these includes a 
methylated nitrogen atom N─CH
3
 at one end of the molecule which is also found in the 
neurotransmitter acetylcholine. Hence, they are capable of blocking or inhibiting nerve 
impulses between nerves in the brain and neuromuscular junctions. Atropine is an alka-
loid which stimulates the central nervous system. Its sulfate salt is injected intramuscularly 
prior to induction of anesthesia. Reduction in pulse range and cessation of cardiac action 
are attributable to increased vigil activity administered intravenously during surgery. 
Scopolamine or hyoscine is an alkaloid that has a depressant activity on the central nervous 
system. Thus, scopolamine hydrobromide is used for preanesthetic sedation in conjunction 
with analgesics. Diterpenoid alkaloids (DAs) isolated from Delphinium and Aconitum plant 
species possess local anesthetic activity by suppressing sodium currents of excited mem-
branes [22, 59, 101, 102].
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6.14. Alkaloids for pain and pleasure
Despite alkaloids and other psychoactive chemicals came from nature act as defensive mol-
ecules for the organisms that made them, these types of molecules can be quite addictive 
drugs to humans. Many alkaloid substances like cocaine, caffeine, nicotine, opium (mor-
phine, heroine), etc. act on the peripheral nervous system with the psychological side effects 
that produce a state of relaxed, mental excitement, and euphoria which are referred to 
addiction.
Medically useful alkaloids morphine and codeine are the pain relievers but also addictive 
drugs. Morphine is stronger than codeine, while codeine is often prescribed for moder-
ate pain and also an effective cough suppressant. Heroin is another abused alkaloid drug 
derived from morphine by a simple chemical modification. However, heroin is metabolized 
to morphine once it enters the body; thus, these two alkaloids drugs are considered com-
pletely equivalent.
Cocaine is produced from the coca plant and classified as narcotic. The effects of cocaine can 
be sorted, excited, and elated, an impression of enhanced physical strength and mental ability 
feelings. There after elevated heart rate and blood pressure are accompanied to these feelings. 
However, cocaine produces a state of euphoric hyperarousal for a short duration; hence, the 
addicted person needs high dose of the drug that may lead to fibrillation and death. Cocaine 
usage over time can result in paranoid schizophrenia.
Nicotine is another alkaloid that is pleasurable and addictive mainly known for tobacco 
plants, whereas potatoes, eggplant, cauliflower, and tomato can be listed as nicotine sources. 
Nicotine alkaloids have primarily stimulation properties and produce either relaxation or 
arousal.
There are other alkaloids which are not addictive, but stimulants such as caffeine and the 
analog compounds theophylline and theobromine are. Caffeine occurs naturally in coffee, tea, 
cocoa and chocolate, cola drinks, and a variety of other plants. Tea contains small amounts of 
theophylline apart from caffeine, while theobromine is the major stimulant in cocoa. Cocoa 
and chocolate contain neuroactive alkaloids known as tetrahydro-beta-carbolines that pos-
sibly have influences on mood and behavior [23, 24, 103–108].
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